Crude | Adjusted | |||
---|---|---|---|---|
OR (95 % CI) | P value | OR (95 % CI) | P value | |
Warfarin with normal physiology (T-RTS = 12) | ||||
Age | 1.138 (1.062, 1.219) | < 0.001 | 1.125 (1.040, 1.216) | 0.003 |
Gender | 0.785 (0.228, 2.701) | 0.701 | ||
Warfarin | 13.417 (3.751, 47.992) | < 0.001 | 8.278 (1.969, 34.794) | 0.004 |
Trauma mechanism | 0.500 (0.131, 1.908) | 0.310 | ||
ASA-PS | 3.707 (1.630, 8.428) | 0.002 | ||
NISS | 1.088 (1.028, 1.153) | 0.004 | 1.088 (1.014, 1.168) | 0.019 |
Warfarin with physiological derangement (T-RTS ≤ 11) | ||||
Age | 1.066 (1.024, 1.110) | 0.002 | 1.090 (1.039, 1.143) | < 0.001 |
Gender | 1.887 (0.905, 3.934) | 0.090 | ||
Warfarin | 1.150 (0.424, 3.120) | 0.784 | ||
Trauma mechanism | 1.065 (0.483, 2.347) | 0.877 | ||
ASA-PS | 1.257 (0.862, 1.833) | 0.234 | ||
NISS | 1.056 (1.028, 1.084) | < 0.001 | 1.064 (1.035, 1.095) | < 0.001 |
Platelet inhibitors | ||||
Age | 1.036 (1.008, 1.064) | 0.010 | 1.081 (1.039, 1.123) | < 0.001 |
Gender | 1.583 (0.882, 2.842) | 0.124 | ||
Platelet inhibitors | 1.033 (0.514, 2.075) | 0.927 | ||
Trauma mechanism | 0.838 (0.450, 1.561) | 0.578 | ||
ASA-PS | 1.304 (0.927, 1.834) | 0.128 | ||
NISS | 1.089 (1.065, 1.114) | < 0.001 | 1.070 (1.042, 1.097) | < 0.001 |
T-RTS | 0.483 (0.396, 0.590) | < 0.001 | 0.582 (0.453, 0.749) | < 0.001 |